Arkolith/Insider Trading/GMED/Form 4

Lemaitre Dan

DirectorGLOBUS MEDICAL INC (GMED) · full profile →Form 4 · filed Nov 25, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2024Sell(S)1K$85.02$93K0
Nov 22, 2024Option exercise(M)1K$65.05$71K1K
Nov 21, 2024Option exercise(M)13K$65.05$864K13K
Nov 21, 2024Sell(S)13K$85.00$1.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 22, 2024Option exercise(M)1K—$0625
Nov 21, 2024Option exercise(M)13K—$02K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-130597) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML